USANA Health Sciences, Inc. USNA
NYSE
| 10/03/2026 | 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | |
|---|---|---|---|---|---|
| Revenue | -0.78% | 1.57% | 5.67% | 8.28% | 5.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.78% | 1.57% | 5.67% | 8.28% | 5.88% |
| Cost of Revenue | 8.37% | 14.16% | 21.84% | 24.59% | 15.17% |
| Gross Profit | -3.18% | -1.59% | 1.76% | 4.49% | 3.68% |
| SG&A Expenses | -1.75% | 1.76% | 4.52% | 8.86% | 9.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.48% | 4.44% | 8.17% | 12.11% | 10.64% |
| Operating Income | -22.47% | -35.62% | -25.17% | -31.79% | -39.19% |
| Income Before Tax | -100.13% | -96.07% | -38.99% | -45.61% | -48.37% |
| Income Tax Expenses | -2.67% | 6.78% | -0.19% | -12.37% | -20.86% |
| Earnings from Continuing Operations | -267.90% | -183.99% | -73.73% | -72.71% | -67.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,560.14% | 1,102.12% | -432.93% | -2,290.00% | -- |
| Net Income | -224.77% | -164.96% | -74.57% | -74.40% | -68.74% |
| EBIT | -22.47% | -35.62% | -25.17% | -31.79% | -39.19% |
| EBITDA | -8.48% | -16.09% | -4.36% | -6.38% | -18.50% |
| EPS Basic | -228.47% | -166.61% | -73.96% | -74.46% | -68.56% |
| Normalized Basic EPS | 3.70% | -18.98% | -25.76% | -34.60% | -39.52% |
| EPS Diluted | -230.75% | -167.34% | -74.02% | -74.69% | -68.91% |
| Normalized Diluted EPS | 3.78% | -18.93% | -25.68% | -34.46% | -39.40% |
| Average Basic Shares Outstanding | -1.70% | -2.99% | -3.67% | -2.97% | -2.11% |
| Average Diluted Shares Outstanding | -1.76% | -3.06% | -3.78% | -3.17% | -2.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |